Bulletin du Cancer Oncology

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →